Molina Healthcare’s (MOH) Hold Rating Reiterated at Raymond James Financial

Raymond James Financial restated their hold rating on shares of Molina Healthcare (NYSE:MOH) in a research note released on Friday.

Other research analysts also recently issued reports about the company. Jefferies Group increased their target price on Molina Healthcare from $60.00 to $64.00 and gave the company a hold rating in a research report on Friday, October 13th. Wolfe Research upgraded Molina Healthcare from a market perform rating to an outperform rating in a research report on Monday, October 23rd. Morgan Stanley increased their target price on Molina Healthcare from $68.00 to $89.00 and gave the company an overweight rating in a research report on Friday, November 3rd. ValuEngine downgraded Molina Healthcare from a buy rating to a hold rating in a research report on Friday, December 1st. Finally, Zacks Investment Research upgraded Molina Healthcare from a sell rating to a hold rating in a research report on Monday, November 6th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of $64.30.

Molina Healthcare (NYSE MOH) opened at $75.11 on Friday. Molina Healthcare has a 52 week low of $42.56 and a 52 week high of $80.74. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $4,288.33, a P/E ratio of 23.33 and a beta of 0.97.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The business had revenue of $5.03 billion during the quarter, compared to the consensus estimate of $4.95 billion. During the same quarter in the previous year, the company earned $0.85 earnings per share. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. equities analysts anticipate that Molina Healthcare will post -3.88 earnings per share for the current fiscal year.

In related news, insider William Dentino sold 22,500 shares of the stock in a transaction on Wednesday, October 11th. The stock was sold at an average price of $63.96, for a total transaction of $1,439,100.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Terry Bayer sold 9,077 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $77.45, for a total value of $703,013.65. Following the sale, the chief operating officer now owns 74,478 shares in the company, valued at approximately $5,768,321.10. The disclosure for this sale can be found here. Insiders have sold a total of 407,523 shares of company stock worth $28,505,592 in the last 90 days. 6.20% of the stock is currently owned by insiders.

A number of large investors have recently added to or reduced their stakes in MOH. Zions Bancorporation purchased a new stake in Molina Healthcare in the third quarter worth $118,000. LS Investment Advisors LLC increased its stake in Molina Healthcare by 40.9% in the second quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock worth $127,000 after purchasing an additional 531 shares during the period. Tiedemann Wealth Management LLC increased its stake in Molina Healthcare by 7.8% in the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after purchasing an additional 103,775 shares during the period. Riverhead Capital Management LLC increased its stake in Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock worth $170,000 after purchasing an additional 963 shares during the period. Finally, Sabal Trust CO purchased a new stake in Molina Healthcare in the third quarter worth $206,000. Institutional investors own 96.23% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was reported by Week Herald and is owned by of Week Herald. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://weekherald.com/2017/12/11/molina-healthcares-moh-hold-rating-reiterated-at-raymond-james-financial.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply